HARP
COM:HARPOONTX
Harpoon Therapeutics, Inc.
- Stock
Last Close
22.99
08/03 21:00
Market Cap
865.08M
Beta: -
Volume Today
6.40M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 727.50K - | 2.77M 280.14% | 3.48M 25.67% | 2.08M 40.07% | 2.12M 1.73% | 3.69M 74.09% | ||
average receivables | 3.38M - | |||||||
book value per share | -1.11 - | -3.90 253.16% | -2.24 42.70% | 4.33 293.70% | 2.15 50.36% | 1.80 16.33% | 0.16 90.95% | |
capex per share | -0.06 - | -0.33 463.18% | -0.03 91.59% | -0.16 483.05% | -0.03 83.13% | -0.00 88.64% | -0.01 237.66% | |
capex to depreciation | -2.79 - | -6.22 122.56% | -1.03 83.44% | -3.91 279.47% | -0.33 91.60% | -0.05 86.08% | -0.15 222.41% | |
capex to operating cash flow | 0.05 - | -1.33 2,690.76% | 0.02 101.84% | 1.22 4,875.92% | 0.08 93.48% | 0.00 98.97% | 0.00 375.29% | |
capex to revenue | -3.21 - | -0.14 95.66% | -0.61 336.04% | -0.04 93.57% | -0.00 89.20% | -0.01 157.18% | ||
cash per share | 0.10 - | 4.26 3,989.22% | 3.74 12.20% | 9.86 163.48% | 5.03 48.95% | 4.19 16.85% | 1.60 61.74% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | ||||||||
debt to assets | 2.25 - | 1.85 17.83% | 1.52 17.56% | 0.47 69.34% | 0.69 47.11% | 0.63 8.71% | 0.93 47.94% | |
debt to equity | -1.80 - | -2.18 21.09% | -2.92 33.68% | 0.87 129.96% | 2.19 150.14% | 1.68 23.33% | 12.66 654.69% | |
dividend yield | ||||||||
earnings yield | -0.09 - | -0.18 101.99% | -0.08 53.06% | -0.16 90.83% | -0.11 31.03% | -0.48 329.14% | -2.79 482.45% | |
enterprise value | 128.88M - | 63.75M 50.53% | 233.28M 265.93% | 181.45M 22.22% | 408.18M 124.96% | 211.17M 48.26% | -11.54M 105.46% | |
enterprise value over ebitda | -11.77 - | -3.94 66.53% | -8.73 121.55% | -3.12 64.29% | -7.95 155.09% | -14.41 81.23% | 0.17 101.17% | |
ev to operating cash flow | -11.94 - | 37.19 411.51% | -8.60 123.12% | -62.76 629.81% | -47.37 24.52% | -1.73 96.35% | 0.13 107.48% | |
ev to sales | 90.04 - | 49.11 45.46% | 31.41 36.05% | 23.40 25.50% | 8.93 61.85% | -0.36 104.05% | ||
free cash flow per share | -1.20 - | -0.08 93.23% | -1.16 1,329.89% | -0.29 74.65% | -0.37 26.07% | -3.79 919.80% | -2.70 28.74% | |
free cash flow yield | -0.09 - | -0.01 93.23% | -0.09 1,329.89% | -0.02 76.86% | -0.02 12.26% | -0.50 2,143.56% | -3.72 641.37% | |
graham net net | -1.35 - | -4.26 214.83% | -2.78 34.62% | 6.07 318.15% | 0.33 94.56% | 1.17 253.46% | -0.46 139.26% | |
graham number | 5.48 - | 14.64 167.09% | 7.59 48.14% | 15.27 101.24% | 9.47 37.99% | 12.10 27.75% | 2.72 77.49% | |
income quality | 0.95 - | -0.10 110.76% | 0.99 1,073.30% | 0.05 94.75% | 0.17 231.85% | 1.05 506.21% | 1.32 25.81% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -42.71 - | -57.99 35.79% | 3.89K - | 115.03 97.04% | ||||
interest debt per share | 0.03 - | 0.04 49.48% | 0.69 - | 0.54 21.44% | 0.38 30.23% | 0.46 23.36% | ||
inventory turnover | ||||||||
invested capital | 0.16 - | 0.25 58.27% | 0.21 16.40% | 2.96 1,312.62% | ||||
market cap | 127.55M - | 93.17M 26.95% | 322.77M 246.42% | 321.63M 0.35% | 415.83M 29.29% | 243.67M 41.40% | 24.07M 90.12% | |
net current asset value | -10.53M - | -29.17M 176.89% | -65.84M 125.71% | 68.23M 203.64% | 12.00M 82.41% | 40.31M 235.91% | -13.60M 133.74% | |
net debt to ebitda | -0.12 - | 1.82 1,600.24% | 3.35 84.16% | 2.41 28.09% | 0.15 93.81% | 2.22 1,387.28% | 0.52 76.50% | |
net income per share | -1.21 - | -2.44 101.99% | -1.14 53.06% | -2.39 109.07% | -1.85 22.54% | -3.62 95.07% | -2.02 44.02% | |
operating cash flow per share | -1.14 - | 0.25 121.74% | -1.13 556.84% | -0.13 88.28% | -0.34 158.88% | -3.78 999.74% | -2.69 28.96% | |
payables turnover | ||||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | 19.24 - | 5.55 71.15% | 7.20 29.70% | 3.01 58.15% | 3.05 1.19% | 2.55 16.36% | ||
return on tangible assets | -1.36 - | -0.53 61.19% | -0.27 49.48% | -0.29 10.45% | -0.27 8.22% | -0.75 177.58% | -0.91 21.31% | |
revenue per share | 0.10 - | 0.20 93.67% | 0.27 33.72% | 0.70 162.29% | 0.73 5.18% | 0.96 31.29% | ||
roe | 1.09 - | 0.62 42.80% | 0.51 18.08% | -0.55 207.93% | -0.86 56.05% | -2.01 133.15% | -12.44 518.82% | |
roic | -1.82 - | 0.59 132.31% | 0.34 41.54% | 0.40 16.54% | -0.37 193.44% | -1.84 392.43% | 1.98 207.55% | |
sales general and administrative to revenue | 5.10 - | 1.29 74.82% | 3.88 201.51% | 0.93 76.02% | 0.77 16.62% | 0.59 23.78% | ||
shareholders equity per share | -1.11 - | -3.90 253.16% | -2.24 42.70% | 4.33 293.70% | 2.15 50.36% | 1.80 16.33% | 0.16 90.95% | |
stock based compensation to revenue | 0.52 - | 0.14 72.71% | 0.36 153.40% | 0.28 22.28% | 0.40 43.58% | 0.27 32.35% | ||
tangible asset value | -10.44M - | -26.94M 157.98% | -53.48M 98.49% | 94.22M 276.18% | 53.84M 42.86% | 58.07M 7.86% | 5.40M 90.70% | |
tangible book value per share | -1.11 - | -3.90 253.16% | -2.24 42.70% | 4.33 293.70% | 2.15 50.36% | 1.80 16.33% | 0.16 90.95% | |
working capital | 4.43M - | 22.73M 412.88% | 78.28M 244.35% | 128.10M 63.66% | 81.84M 36.12% | 78.56M 4.01% | 2.29M 97.08% |
All numbers in USD (except ratios and percentages)